{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:31:26Z","timestamp":1789115486110,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.berh.2026.102166","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:40:02Z","timestamp":1788378002000},"page":"102166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Managing comorbidities in psoriatic arthritis: A state-of-the-art approach to integrated care (2025)"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7210-9306","authenticated-orcid":false,"given":"Stephanie","family":"Tancer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elaine Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.berh.2026.102166_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic Arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.autrev.2018.11.007","article-title":"Amplifying the concept of psoriatic arthritis: the role of autoimmunity in systemic psoriatic disease","volume":"18","author":"Chimenti","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"19","key":"10.1016\/j.berh.2026.102166_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197041","article-title":"The risk of systemic diseases in those with psoriasis and psoriatic arthritis: from mechanisms to clinic","volume":"21","author":"Woo","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12016-021-08914-w","article-title":"The Conundrum of psoriatic arthritis: a pathogenetic and clinical pattern at the midpoint of autoinflammation and autoimmunity","volume":"65","author":"Scrivo","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib151","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000152","article-title":"Recognizing and managing comorbidities in psoriatic arthritis","volume":"27","author":"Ogdie","year":"2015","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib152","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","article-title":"Comorbidities in psoriatic arthritis","volume":"41","author":"Husni","year":"2015","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.berh.2026.102166_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108397","article-title":"Comorbidities associated with psoriatic arthritis: review and update","volume":"214","author":"Perez-Chada","year":"2020","journal-title":"Clinical Immunology (Orlando, Fla)"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib154","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3899\/jrheum.141359","article-title":"Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study","volume":"43","author":"Haque","year":"2016","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/acr.25230","article-title":"Comorbidities in early psoriatic arthritis: data from the metabolic disturbances in psoriatic arthritis cohort study","volume":"76","author":"Ishchenko","year":"2024","journal-title":"Arthritis Care Res"},{"issue":"13","key":"10.1016\/j.berh.2026.102166_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.berh.2026.102166_bib14","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.jacc.2023.09.819","article-title":"Novel imaging approaches to cardiac manifestations of systemic inflammatory diseases: JACC scientific statement","volume":"82","author":"Weber","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National psoriasis foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2026.102166_bib16","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s10067-022-06484-6","article-title":"Autonomic dysfunction and cardiovascular risk in psoriatic arthritis","volume":"42","author":"Gezer","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102166_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103889","article-title":"Cardiovascular risk in psoriatic arthritis: how can we manage it?","author":"Atzeni","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2026.102166_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970371","article-title":"The cardiometabolic conditions of psoriatic disease","volume":"13","author":"Toussirot","year":"2022","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.berh.2026.102166_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11926-017-0692-2","article-title":"Cardiometabolic disorders in psoriatic disease","volume":"19","author":"Sobchak","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90684-8","article-title":"Psoriatic disease is associated with systemic inflammation, endothelial activation, and altered haemostatic function","volume":"11","author":"Visser","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2026.102166_bib155","doi-asserted-by":"crossref","DOI":"10.1177\/21501319241309168","article-title":"Metabolic syndrome: an updated review on diagnosis and treatment for primary care clinicians","volume":"15","author":"Peterseim","year":"2024","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.berh.2026.102166_bib20","article-title":"The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies","author":"Haberman","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2025.105904","article-title":"Weighing in on obesity and psoriatic arthritis - time to move beyond association to robust randomised trials","volume":"92","author":"Siebert","year":"2025","journal-title":"Jt Bone Spine"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaad.2020.08.060","article-title":"Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational studies","volume":"84","author":"Xie","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13075-023-03085-9","article-title":"More than skin-deep: visceral fat is strongly associated with disease activity, function and metabolic indices in psoriatic disease","volume":"25","author":"Blake","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2026.102166_bib24","article-title":"Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis","volume":"11","author":"Porta","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/rheumatology\/kes242","article-title":"Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management","volume":"52","author":"Russolillo","year":"2013","journal-title":"Rheumatology (Oxford, England)"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib26","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240677","article-title":"Adipose tissue harbors pathogenic T cells in obesity that exacerbate inflammatory arthritis","volume":"222","author":"Faust","year":"2025","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/key286","article-title":"Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study","volume":"58","author":"Charlton","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"10.1016\/j.berh.2026.102166_bib31","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.3390\/jcm12185814","article-title":"Molecular background and clinical implications of glucose disorders in patients with psoriatic arthritis","volume":"12","author":"Grygiel-G\u00f3rniak","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib32","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jid.2020.11.025","article-title":"Causal relationship and shared genetic loci between psoriasis and type 2 diabetes through trans-disease meta-analysis","volume":"141","author":"Patrick","year":"2021","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clinthera.2023.01.006","article-title":"Comorbidities in psoriatic arthritis: a narrative review","volume":"45","author":"Panagiotopoulos","year":"2023","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib34","article-title":"Cardiovascular disease and depression in psoriatic arthritis: multidimensional comorbidities requiring multidisciplinary management. Best practice & research","volume":"35","author":"So","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"Special article: 2018 American college of Rheumatology\/National Psoriasis foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2026.102166_bib123","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"GRAPPA treatment recommendations domain subcommittees. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2026.102166_bib35","article-title":"Cardiovascular imaging in psoriasis: a critical review of current evidence, techniques, and therapeutic implications","author":"Tartaglia","year":"2025","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13075-023-03105-8","article-title":"Serum IL-23 significantly decreased in Obese patients with psoriatic arthritis six months after a structured weight loss intervention","volume":"25","author":"Landgren","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105647","article-title":"Weight loss affects disease activity and treatment response in inflammatory rheumatic diseases","volume":"91","author":"Tournadre","year":"2024","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.berh.2026.102166_bib40","article-title":"The risk of cardiovascular events following treatment for psoriatic arthritis with a biological agent","author":"Hsu","year":"2025","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib42","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2018.11.058","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","volume":"80","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004591","article-title":"Cardiovascular disease risk in patients with psoriasis receiving biologics targeting TNF-\u03b1, IL-12\/23, IL-17, and IL-23: a population-based retrospective cohort study","volume":"22","author":"Lin","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.berh.2026.102166_bib156","article-title":"Excess cardiovascular morbidity in psoriatic arthritis and cardioprotective effects of biologic dmards: a propensity-matched analysis","volume":"22","author":"Tyczy\u0144ska","year":"2026","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaad.2018.11.057","article-title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","volume":"80","author":"Menter","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jbspin.2018.03.007","article-title":"Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis","volume":"86","author":"Shan","year":"2019","journal-title":"Jt Bone Spine"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib46","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1007\/s00125-011-2232-3","article-title":"Glucagon-like Peptide-1 (GLP-1), and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis","volume":"54","author":"Hogan","year":"2011","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103864","article-title":"Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: a review of current evidence and future directions","volume":"24","author":"Bilgin","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2026.102166_bib142","article-title":"GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study","author":"Olbrich","year":"2025","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib73","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.semarthrit.2020.02.001","article-title":"Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta-analysis","volume":"50","author":"Zusman","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib74","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00296-024-05617-1","article-title":"Psoriatic arthritis with psychological comorbidities: an overview of systematic reviews on incidence, prevalence, and geographic disparities","volume":"44","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2024","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-020-02294-w","article-title":"Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates","volume":"22","author":"Haugeberg","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib76","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jaclp.2021.12.007","article-title":"Depression and suicidality in patients with psoriasis and the role of psoriatic arthritis: a cross-sectional study in a tertiary setting","volume":"63","author":"Lada","year":"2022","journal-title":"J Acad Consult Liaison Psychiatry"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib77","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s10067-020-05417-5","article-title":"Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role?","volume":"40","author":"De Lorenzis","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2026.102166_bib146","article-title":"Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review","volume":"12","author":"Volkmar","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib78","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jdv.19192","article-title":"Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation","volume":"37","author":"Mrowietz","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib79","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bjd\/ljac132","article-title":"Factors associated with depression, anxiety, and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis","volume":"188","author":"Adesanya","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.berh.2026.102166_bib157","article-title":"The complex interplay between psoriasis and depression: from molecular mechanisms to holistic treatment approaches","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib80","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/03009742.2022.2044116","article-title":"Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures","volume":"52","author":"Skougaard","year":"2023","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","article-title":"The psychosocial burden of psoriatic arthritis","volume":"47","author":"Husni","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/1744666X.2021.1905522","article-title":"The association between IL17, fatigue and quality of life in psoriatic arthritis patients","volume":"17","author":"Gado","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaad.2024.02.026","article-title":"Characteristics and drivers of fatigue in patients with psoriasis and psoriatic arthritis: a cross-sectional study","volume":"91","author":"Nymand","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib84","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00296-020-04678-2","article-title":"Prevalence and variables associated with fatigue in psoriatic arthritis: a cross-sectional study","volume":"40","author":"Tan","year":"2020","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib82","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00296-020-04628-y","article-title":"The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network","volume":"40","author":"Duru\u00f6z","year":"2020","journal-title":"Rheumatol Int"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib85","first-page":"1221","article-title":"Effect of fatigue on health-related quality of life and work productivity in psoriatic arthritis: findings from a Real-World Survey","volume":"49","author":"Gossec","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2026.102166_bib86","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.2022-1169","article-title":"Sleep problems in patients with psoriatic arthritis: a systematic literature review and metaanalysis","author":"Grant","year":"2023","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48723-z","article-title":"SLEEP quality in patients with psoriatic arthritis and its relationship with disease activity and comorbidities: a cross-sectional study","volume":"13","author":"Toledano","year":"2023","journal-title":"Sci Rep"},{"issue":"45","key":"10.1016\/j.berh.2026.102166_bib88","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000045699","article-title":"Obstructive sleep apnea in psoriatic arthritis: a polysomnography-based evaluation","volume":"104","author":"Mustafa","year":"2025","journal-title":"Medicine (Baltim)"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib108","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/annrheumdis-2020-217892","article-title":"Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study","volume":"79","author":"Xia","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14630","article-title":"The association between psoriasis and psoriatic arthritis with the risk of osteoporosis, osteopenia, and bone fractures: a systematic review and meta-analysis","volume":"75","author":"Sepehri","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib110","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.3390\/jcm9113712","article-title":"Bone mineral density, osteoporosis, and fracture risk in adult patients with psoriasis or psoriatic arthritis: a systematic review and meta-analysis of observational studies","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib111","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/acr.24538","article-title":"Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis","volume":"74","author":"Kwok","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib107","article-title":"Risk of end-stage renal disease in psoriatic patients: Real-world data from a nationwide population-based cohort study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.berh.2026.102166_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038007","article-title":"Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: a systematic review, meta-analysis, and trial sequential analysis","volume":"103","author":"Hu","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib28","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1038\/s41598-021-88043-8","article-title":"Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients","volume":"11","author":"Belinch\u00f3n-Romero","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib29","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3390\/ijms25052660","article-title":"Intersecting pathways: nonalcoholic fatty liver disease and psoriasis Duet-a comprehensive review","volume":"25","author":"Costache","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.berh.2026.102166_bib105","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1038\/s41598-021-88043-8","article-title":"Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients","volume":"11","author":"Belinch\u00f3n-Romero","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.berh.2026.102166_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1294416","article-title":"Short-term risk and long-term incidence rate of infection and malignancy with IL-17 and IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105673","article-title":"Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: a meta-analysis of randomized controlled trials","volume":"91","author":"S\u00e9auve","year":"2024","journal-title":"Jt Bone Spine"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/annrheumdis-2019-216102","article-title":"Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis","volume":"79","author":"Li","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib100","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/acr.24630","article-title":"Risk of hospitalization for serious infection after initiation of ustekinumab or other biologics in patients with psoriasis or psoriatic arthritis","volume":"74","author":"Jin","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.berh.2026.102166_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.992713","article-title":"The incidence of opportunistic infections in patients with psoriatic arthritis treated with biologic and targeted synthetic agents: a systematic review and meta-analysis","volume":"13","author":"Vassilopoulos","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamadermatol.2022.3682","article-title":"Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis: a bidirectional 2-Sample mendelian randomization study","volume":"158","author":"Freuer","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib55","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.2024.20917","article-title":"Axial spondyloarthritis: a review","volume":"333","author":"Bittar","year":"2025","journal-title":"JAMA"},{"issue":"10473","key":"10.1016\/j.berh.2026.102166_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","article-title":"Axial spondyloarthritis","volume":"405","author":"Navarro-Comp\u00e1n","year":"2025","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.berh.2026.102166_bib57","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41584-023-01038-9","article-title":"Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis","volume":"19","author":"McGonagle","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib58","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.berh.2018.08.002","article-title":"Uveitis and spondyloarthropathies","volume":"31","author":"Sharma","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib144","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00296-023-05424-0","article-title":"Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study","volume":"43","author":"Kougkas","year":"2023","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.berh.2026.102166_bib59","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/acr.25308","article-title":"Screening tools for spondyloarthritis in patients with psoriasis, uveitis, and inflammatory bowel disease: a scoping review","volume":"76","author":"Kesarwani","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.42315","article-title":"Keep an eye on the back: spondyloarthritis in patients with acute anterior uveitis","volume":"75","author":"Rademacher","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2026.102166_bib64","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s40265-022-01750-y","article-title":"Spondyloarthropathy in inflammatory bowel disease: from pathophysiology to pharmacological targets","volume":"82","author":"Crispino","year":"2022","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib65","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.clinthera.2023.05.010","article-title":"Pharmacologic treatment strategies in psoriatic arthritis","volume":"45","author":"Ayan","year":"2023","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/BOR.0000000000000619","article-title":"The use of biologics for uveitis associated with spondyloarthritis","volume":"31","author":"Arepalli","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib67","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/jgh.16612","article-title":"The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"39","author":"Zheng","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.berh.2026.102166_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103853","article-title":"Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis","volume":"24","author":"Akiyama","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.berh.2026.102166_bib72","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/14712598.2024.2384090","article-title":"The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis","volume":"24","author":"Caso","year":"2024","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rdc.2025.05.009","article-title":"Combined dermatology\/rheumatology clinics for management of psoriatic disease: current state","volume":"51","author":"Ruderman","year":"2025","journal-title":"Rheum Dis Clin N Am"},{"issue":"22","key":"10.1016\/j.berh.2026.102166_bib2","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.3390\/jcm14228151","article-title":"Psoriatic arthritis: from diagnosis to treatment","volume":"14","author":"Kannappan","year":"2025","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"10.1016\/j.berh.2026.102166_bib129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.2024-0621","article-title":"Breakout session, and report back: collaboration of rheumatologists and dermatologists for the care of patients with psoriatic disease","volume":"51","author":"Stolnicki","year":"2024","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2026.102166_bib130","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12325-023-02667-y","article-title":"The effect of an interdisciplinary dermatological-rheumatological consultation on the outcome of patients with psoriasis with musculoskeletal pain: a prospective, single-center cohort study","volume":"40","author":"von Ahnen","year":"2023","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ced.14390","article-title":"Analysis of the first 5 years of an interdisciplinary Rheumatology-Dermatology clinic","volume":"46","author":"Argobi","year":"2021","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/annrheumdis-2017-211998","article-title":"Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort","volume":"77","author":"van Mens","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2026.102166_bib126","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/annrheumdis-2020-217301","article-title":"Mixed methods study of clinicians' perspectives on barriers to implementation of treat to target in psoriatic arthritis","volume":"79","author":"Dures","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2026.102166_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152546","article-title":"Barriers, and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: a systematic literature review","volume":"69","author":"Webers","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"10136","key":"10.1016\/j.berh.2026.102166_bib124","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/S0140-6736(18)30949-8","article-title":"Clinical management of psoriatic arthritis","volume":"391","author":"Van den Bosch","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.berh.2026.102166_bib135","doi-asserted-by":"crossref","DOI":"10.2196\/14753","article-title":"Evaluation of Mobile apps targeted at patients with spondyloarthritis for disease monitoring: systematic app search","volume":"7","author":"Kwan","year":"2019","journal-title":"JMIR mHealth uHealth"},{"key":"10.1016\/j.berh.2026.102166_bib136","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdin.2023.02.018","article-title":"National Psoriasis foundation telemedicine task force guidance for management of psoriatic disease via telemedicine","volume":"12","author":"Pelet Del Toro","year":"2023","journal-title":"JAAD Int"},{"issue":"5 Suppl 101","key":"10.1016\/j.berh.2026.102166_bib137","first-page":"S62","article-title":"Electronic health records in rheumatology: emphasis on automated scoring and additional use","volume":"34","author":"Richter","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib138","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2665-9913(21)00349-0","article-title":"The state of the art-psoriatic arthritis outcome assessment in clinical trials and daily practice","volume":"4","author":"Day","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.berh.2026.102166_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152271","article-title":"Teleconsultation in rheumatology: a literature review and opinion paper","volume":"63","author":"Avouac","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2026.102166_bib140","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/rheumatology\/keac708","article-title":"Controversies in rheumatology: telemedicine-friend or foe?","volume":"62","author":"Dejaco","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2026.102166_bib149","article-title":"Building consensus on the essential elements of the musculoskeletal physical examination during rheumatology telehealth encounters","author":"Zickuhr","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.berh.2026.102166_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/1744666X.2016.1139453","article-title":"Psoriatic arthritis: complexities, comorbidities, and implications for the clinic","volume":"12","author":"Haroon","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.berh.2026.102166_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/rheumatology\/keae172","article-title":"Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel","volume":"64","author":"Coates","year":"2025","journal-title":"Rheumatology (Oxford, England)"},{"issue":"40","key":"10.1016\/j.berh.2026.102166_bib103","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027368","article-title":"Risk of herpes zoster associated with biological therapies for psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"100","author":"Zou","year":"2021","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.berh.2026.102166_bib104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamadermatol.2025.0144","article-title":"Systemic therapies for psoriatic disease and serious infections in older adults","volume":"161","author":"Drucker","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.berh.2026.102166_bib97","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cgh.2023.07.027","article-title":"Risk of cancer recurrence in patients with immune-mediated diseases with use of immunosuppressive therapies: an updated systematic review and meta-analysis","volume":"22","author":"Gupta","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.berh.2026.102166_bib102","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1097\/CM9.0000000000001810","article-title":"Risk factors associated with osteoporosis and fracture in psoriatic arthritis","volume":"134","author":"Wang","year":"2021","journal-title":"Chin Med J (Engl)"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694226000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:36:40Z","timestamp":1789112200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694226000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1521694226000513"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2026.102166","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing comorbidities in psoriatic arthritis: A state-of-the-art approach to integrated care (2025)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2026.102166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102166"}}